Enliven Therapeutics (ELVN) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free ELVN Stock Alerts $23.71 -0.78 (-3.18%) (As of 12:51 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Enliven Therapeutics Short Interest DataCurrent Short Volume4,640,000 sharesPrevious Short Volume4,230,000 sharesChange Vs. Previous Month+9.69%Dollar Volume Sold Short$92.52 millionShort Interest Ratio / Days to Cover18.7Last Record DateApril 15, 2024Outstanding Shares47,010,000 sharesFloat Size25,320,000 sharesShort Percent of Float18.33%Today's Trading Volume282,366 sharesAverage Trading Volume246,835 sharesToday's Volume Vs. Average114% Short Selling Enliven Therapeutics ? Sign up to receive the latest short interest report for Enliven Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatELVN Short Interest Over TimeELVN Days to Cover Over TimeELVN Percentage of Float Shorted Over Time Ad InvestorPlace1970’s computer coder Issues Shocking AI WarningLouis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP Enliven Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,640,000 shares $92.52 million +9.7%18.3%18.7 $19.94 3/31/20244,230,000 shares $74.41 million -2.3%19.8%28.5 $17.59 3/15/20244,330,000 shares $51.83 million No Change20.4%30.6 $11.97 2/29/20244,330,000 shares $69.15 million -11.8%20.5%29.2 $15.97 2/15/20244,910,000 shares $84.94 million -4.8%23.3%31.8 $17.30 1/31/20245,160,000 shares $81.01 million +0.2%26.3%36.3 $15.70 Get the Latest News and Ratings for ELVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,150,000 shares $63.35 million -6.5%26.9%39.2 $12.30 12/31/20235,510,000 shares $76.26 million +3.8%28.8%44.9 $13.84 12/15/20235,310,000 shares $63.19 million +1.3%27.3%41.1 $11.90 11/30/20235,240,000 shares $59.00 million +0.4%27.0%54.9 $11.26 11/15/20235,220,000 shares $57.16 million +1.0%26.9%59.3 $10.95 10/31/20235,170,000 shares $64.06 million +1.4%23.5%53.6 $12.39 10/15/20235,100,000 shares $62.48 million -0.6%23.2%51.6 $12.25 9/30/20235,130,000 shares $70.08 million -0.8%23.3%49.8 $13.66 9/15/20235,170,000 shares $83.24 million +1.0%23.7%44.7 $16.10 8/31/20235,120,000 shares $79.97 million -3.4%23.5%26.3 $15.62 8/15/20235,300,000 shares $87.29 million -1.1%24.8%24.2 $16.47 7/31/20235,360,000 shares $101.52 million -1.1%26.1%25.2 $18.94 7/15/20235,420,000 shares $97.99 million +1.3%26.4%24.8 $18.08 6/30/20235,350,000 shares $109.19 million +39.7%26.1%23.4 $20.41 6/15/20233,830,000 shares $74.34 million +29.4%18.7%16.8 $19.41 5/31/20232,960,000 shares $54.17 million +9.2%14.4%21 $18.30 5/15/20232,710,000 shares $53.74 million No Change13.2%22.1 $19.83 ELVN Short Interest - Frequently Asked Questions What is Enliven Therapeutics' current short interest? Short interest is the volume of Enliven Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 4,640,000 shares of ELVN short. 18.33% of Enliven Therapeutics' shares are currently sold short. Learn More on Enliven Therapeutics' current short interest. What is a good short interest ratio for Enliven Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELVN shares currently have a short interest ratio of 19.0. Learn More on Enliven Therapeutics's short interest ratio. What is a good short interest percentage for Enliven Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.33% of Enliven Therapeutics' floating shares are currently sold short. Is Enliven Therapeutics' short interest increasing or decreasing? Enliven Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 4,640,000 shares, an increase of 9.7% from the previous total of 4,230,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Enliven Therapeutics' float size? Enliven Therapeutics currently has issued a total of 47,010,000 shares. Some of Enliven Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enliven Therapeutics currently has a public float of 25,320,000 shares. How does Enliven Therapeutics' short interest compare to its competitors? 18.33% of Enliven Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Enliven Therapeutics: AbCellera Biologics Inc. (11.25%), Verona Pharma plc (7.51%), MannKind Co. (13.21%), Collegium Pharmaceutical, Inc. (22.86%), Mirum Pharmaceuticals, Inc. (18.21%), Pacira BioSciences, Inc. (7.42%), Spyre Therapeutics, Inc. (10.55%), Belite Bio, Inc (0.12%), Prothena Co. plc (12.34%), Gyre Therapeutics, Inc. (1.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Enliven Therapeutics stock? Short selling ELVN is an investing strategy that aims to generate trading profit from Enliven Therapeutics as its price is falling. ELVN shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enliven Therapeutics? A short squeeze for Enliven Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELVN, which in turn drives the price of the stock up even further. How often is Enliven Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELVN, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ABCL Short Interest VRNA Short Interest MNKD Short Interest COLL Short Interest MIRM Short Interest PCRX Short Interest SYRE Short Interest BLTE Short Interest PRTA Short Interest GYRE Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ELVN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold Group